Recombinant Peptidyl Arginine Deiminase Type IV (PADI4)

PAD; PADI5; PDI4; PDI5; Peptidyl Arginine Deiminase Type V; Peptidylarginine deiminase IV

  • Product No.RPF709Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationNucleus, Cytoplasm
  • Predicted Molecular Mass36.3kDa
  • Accurate Molecular Mass36kDa(Analysis of differences refer to the manual)
  • Residues & TagsMet1~Pro300 with N-terminal His Tag
  • Buffer Formulation100mMNaHCO3, 500mMNaCl, pH8.3, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point6.0
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 168  US$ 420  US$ 840  US$ 2520  US$ 6300 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Arthritis Res Ther. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility Pubmed:Pmc4229860
Journal of Molecular Cell Biology Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patients Pubmed:30044533
Journal of Inflammation Research Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery Pubmed: 31213874
Revista da Associacao Medica Brasileira Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPF709Hu01 Recombinant Peptidyl Arginine Deiminase Type IV (PADI4) Positive Control; Immunogen; SDS-PAGE; WB.
PAF709Hu01 Polyclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) WB; IHC; ICC; IP.
MAF709Hu21 Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) WB
MAF709Hu22 Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) WB; IHC; ICC; IP.
MAF709Hu23 Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) WB; IHC; ICC; IP.
MAF709Hu24 Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) WB; IHC; ICC; IP.
SEF709Hu ELISA Kit for Peptidyl Arginine Deiminase Type IV (PADI4) Enzyme-linked immunosorbent assay for Antigen Detection.
LMF709Hu Multiplex Assay Kit for Peptidyl Arginine Deiminase Type IV (PADI4) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.